ASSET | DATE | % RETURN |
---|---|---|
Avalon GloboCare (ALBT) | 3/15/2018 - 5/3/2018 | 3,238,536.36% |
Ambow Education (AMBO) | 3/15/2018 - 5/3/2018 | 19,900% |
Nocera (NCRA) | 3/15/2018 - 5/3/2018 | 816.67% |
Integrated Media Technology (IMTE) | 3/15/2018 - 5/3/2018 | 700.75% |
Creative Medical Technology (CELZ) | 3/15/2018 - 5/3/2018 | 571.43% |
Reliance Global (RELI) | 3/15/2018 - 5/3/2018 | 378% |
Turtle Beach (TBCH) | 3/15/2018 - 5/3/2018 | 216.33% |
Genprex (GNPX) | 3/15/2018 - 5/3/2018 | 206.4% |
CleanSpark (CLSK) | 3/15/2018 - 5/3/2018 | 204.45% |
Ryvyl (RVYL) | 3/15/2018 - 5/3/2018 | 203.03% |
Carisma Therapeutics (CARM) | 3/15/2018 - 5/3/2018 | 186.09% |
OLB (OLB) | 3/15/2018 - 5/3/2018 | 166.67% |
Rafael Holdings Inc Class B (RFL) | 3/15/2018 - 5/3/2018 | 155.74% |
CASI Pharmaceuticals (CASI) | 3/15/2018 - 5/3/2018 | 136.73% |
Eyepoint Pharmaceuticals (EYPT) | 3/15/2018 - 5/3/2018 | 115.7% |
Boxlight Corp Class A (BOXL) | 3/15/2018 - 5/3/2018 | 108.77% |
Tandem Diabetes Care (TNDM) | 3/15/2018 - 5/3/2018 | 105.13% |
Euro Tech (CLWT) | 3/15/2018 - 5/3/2018 | 103.47% |
VERB TECHNOLOGY (VERB) | 3/15/2018 - 5/3/2018 | 96.08% |
Odyssey Marine Exploration (OMEX) | 3/15/2018 - 5/3/2018 | 95.56% |
Tanzanian Royalty Exploration (TRX) | 3/15/2018 - 5/3/2018 | 92.55% |
Immunoprecise Antibodies (IPA) | 3/15/2018 - 5/3/2018 | 87.35% |
NAYA Biosciences (NAYA) | 3/15/2018 - 5/3/2018 | 81.22% |
Relmada Therapeutics (RLMD) | 3/15/2018 - 5/3/2018 | 81.16% |
Caredx (CDNA) | 3/15/2018 - 5/3/2018 | 80.72% |